Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?Zacks Investment Research • 10/07/26
ELTP Downgraded to Neutral on Pricing Pressure & Limited VisibilityZacks Investment Research • 09/10/26
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?Zacks Investment Research • 08/25/26
Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/YZacks Investment Research • 08/19/26
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call InformationNewsfile Corp • 08/13/26
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026Newsfile Corp • 08/10/26
Elite Pharmaceuticals Stock Slips Despite Record Fiscal 2026 EarningsZacks Investment Research • 07/03/26
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call InformationNewsfile Corp • 06/29/26
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026Newsfile Corp • 06/23/26
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence StudyNewsfile Corp • 06/15/26
Elite Pharmaceuticals Announces Filing of Abbreviated New Drug Application with the U.S. Food and Drug Administration for Generic Anticoagulant ProductNewsfile Corp • 06/01/26
Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride TabletsNewsfile Corp • 04/02/26
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue JumpZacks Investment Research • 02/20/26
Elite Pharmaceuticals, Inc. (ELTP) Q3 2026 Earnings Call Prepared Remarks TranscriptSeeking Alpha • 02/19/26
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call InformationNewsfile Corp • 02/17/26
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026Newsfile Corp • 02/11/26
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue PerformanceZacks Investment Research • 11/19/25
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call InformationNewsfile Corp • 11/14/25